Related Experiment Video
Updated: Jun 15, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
[Clinical Features and Prognosis of Secondary Intestinal Diffuse Large B-Cell Lymphoma]
Xiao-Jun Chen1,2, Su-Xia Lin1, Dong-Hui Gan1
1Department of Hematology and Rheumatology, The Affiliated Hospital of Putian University, Putian 351100, Fujian Province, China.
Secondary intestinal diffuse large B-cell lymphoma (SI-DLBCL) primarily affects middle-aged men and presents with non-specific symptoms. The Lugano stage is a key independent prognostic factor for overall survival (OS) and progression-free survival (PFS) in SI-DLBCL patients.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Context:
- Secondary intestinal diffuse large B-cell lymphoma (SI-DLBCL) is a rare extranodal non-Hodgkin lymphoma.
- Understanding its clinical features and prognostic factors is crucial for improving patient outcomes.
- This study analyzes data from 138 SI-DLBCL patients treated at a single center.
Purpose:
- To investigate the clinical characteristics, treatment patterns, and prognostic factors of SI-DLBCL.
- To identify independent predictors of overall survival (OS) and progression-free survival (PFS).
- To provide insights for the diagnosis and management of rare site lymphomas.
Summary:
- The study included 138 patients with SI-DLBCL, predominantly middle-aged men (61.59%).
- Clinical manifestations were non-specific; R-CHOP chemotherapy was the main first-line treatment.
- Five-year OS and PFS rates were 34.06% and 32.61%, respectively.
- Multivariate analysis identified Lugano stage as an independent prognostic factor for both OS and PFS.
Impact:
- Highlights the non-specific presentation of SI-DLBCL, emphasizing the need for high clinical suspicion.
- Confirms the Lugano stage as a critical independent prognostic indicator in SI-DLBCL.
- Provides valuable data for refining treatment strategies and prognostic assessments in rare lymphomas.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Histology of the Small Intestine
The intestinal lining features transverse folds called circular folds, each housing fingerlike projections known as intestinal villi. These villi are covered by a layer of simple columnar epithelium, also referred to as...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

